FIVASA 1600 mg, gastro-resistant tablet 60 tablets
Active ingredients: Mesalazine
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant tablet60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FIVASA 1600 mg, comprimé gastro-résistant
- Pharmaceutical form
- comprimé gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 60 comprimé(s)
- Marketing authorisation holder
- TILLOTTS PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65633046CIP73019987CIP133400930199879Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉSALAZINEcomprimé | 1600 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.